Cidara Therapeutics’ (CDTX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. CDTX has been the topic of a number of other reports. Citizens Jmp assumed coverage on Cidara Therapeutics in a report on Wednesday, March 12th. They […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday,Benzinga reports. CDTX has been the topic of a number of other reports. Citizens Jmp assumed coverage on Cidara Therapeutics in a report on Wednesday, March 12th. They […]
-logo-1200x675.jpg&w=240&h=240&zc=2){kind=logo}
